Combination of C-reactive protein/albumin ratio and time to castration resistance enhances prediction of prognosis for patients with metastatic castration-resistant prostate cancer
Article in Frontiers in Oncology (June 2023)
The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.
The impact of systemic immune-infammation index and serum albumin on the prognosis of castration-resistant prostate cancer patients treated with frst-line docetaxel
Article in Chinese Journal of Metastatic Cancer (September 2022)
Prognostic Role of Pretreatment C-Reactive Protein to Albumin Ratio in Urological Cancers: A Systematic Review and Meta-Analysis
Article in Frontiers in Oncology (April 2022)